May 26, 2016
Eisai launched its antiepileptic drug Fycompa Tablets 2 mg/4 mg (perampanel) in Japan on May 26. Fycompa is a highly selective, noncompetitive AMPA receptor antagonist that reduces neuronal hyperexcitation associated with seizures by targeting glutamate activity at postsynaptic AMPA receptors...read more